IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

Recent studies have demonstrated that IL28B polymorphisms predict therapeutic responses in chronic hepatitis C virus (HCV)-treated patients; however, the effect on HCV viral diversity, particularly on the HCV protease gene, is not clear. This study sought to evaluate the effect of IL28B polymorphism...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Osinusi, Anu, Chary, Aarthi, Winters, Mark A., Naggie, Susanna, Masur, Henry, Polis, Michael A., Kottilil, Shyam, Holodniy, Mark
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3690569/
https://ncbi.nlm.nih.gov/pubmed/22930497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.23376
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky